红日药业(300026.SZ)获得药品GMP证书
格隆汇9月2日丨红日药业(300026.SZ)公布,经国家药品监督管理局现场检查和审核批准,公司通过国家GMP认证,并于近日收到天津市药品监督管理局颁发的《药品GMP证书》,认证范围:大容量注射剂(最终灭菌);有效期至:2024年08月04日。
公司此次通过GMP认证并获发《药品GMP证书》,表明公司大容量注射剂(最终灭菌)生产、质量、仓储等方面均符合《药品生产质量管理规范》(2010年修订)要求。截止目前,红日药业小容量注射剂(最终灭菌、非最终灭菌)(含中药材前处理、中药提取)、大容量注射剂(最终灭菌)均通过GMP认证。
公司通过此次GMP认证,进一步完善了公司质量管理体系,提高了生产质量管理水平和产品质量安全性,同时生产范围进一步扩大,促进了公司产业结构调整和升级,可以更好地满足市场需求,提高市场竞争力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.